MLB has suspended Guillermo Mota for 100 games after the San Francisco reliever’s second positive test for a performance enhancing drug.
Mota first tested positive for a PED in 2006, receiving a 50-game suspension. This time he was found to be using Clenbuterol, which Kirk Radomski famously admitted to giving numerous big leaguers as part of his testimony.
Tour de France winner Alberto Contador also tested positive for Clenbuterol, which led to his being stripped of the 2010 title.
Mota is earning $1 million in his 14th big-league season and the 38-year-old right-hander has a 5.06 ERA in 11 innings for the Giants as a middle reliever.
Interestingly, he served up a homer to Ryan Braun on Saturday in what might prove to be the final appearance of his career.
The Dodgers announced on Thursday that the club activated pitcher Grant Dayton from the 10-day disabled list and designated pitcher Sergio Romo for assignment.
Dayton, 29, went on the disabled list earlier this month with neck stiffness. He’ll resume with a 3.63 ERA and a 20/12 K/BB ratio in 22 1/3 innings.
Romo, 34, signed a one-year, $3 million deal with the Dodgers in February. It didn’t really work out, as the right-hander posted a 6.12 ERA with a 31/12 K/BB ratio in 25 innings. His peripherals are still decent, so it wouldn’t be surprising if a team in need of a bullpen arm makes a deal with the Dodgers within the week.
MLB.com’s Jeffrey Flanagan reports that Royals pitcher Nate Karns underwent surgery for thoracic outlet syndrome on Wednesday. He’s expected to be ready for spring training next year. Karns went on the disabled list in May with an elbow injury and didn’t make much progress.
The Royals acquired Karns from the Mariners in January in exchange for outfielder Jarrod Dyson. Over eight starts and one relief appearance, the 29-year-old right-hander compiled a 4.17 ERA and a 51/13 K/BB ratio in 45 1/3 innings.
Karns will enter his first of three years of arbitration eligibility after the season, so he’ll be under the Royals’ control through 2020.